The anti-MET monoclonal antibody (MetMab) potently inhibited HGF-dependent tumor growth, but showed no effect on tumor cells harboring MET amplification (METamp), despite significant overexpression of MET protein [21]. The gene discussed is HGF; the disease is neoplasm.